Effect of ligand structure on the zinc-catalyzed Henry reaction. Asymmetric syntheses of (-)-denopamine and (-)-arbutamine

Organic Letters

Volumn 4, Issue 16, 2002, Pages 2621-2623

  Trost, Barry M ^a   Yeh, Vince S C ^a   Ito, Hisanako ^a   Bremeyer, Nadine ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARBUTAMINE; CATECHOLAMINE; DENOPAMINE; ETHANOLAMINE DERIVATIVE; LIGAND; ZINC;

ARTICLE; METABOLISM; SYNTHESIS;

CATECHOLAMINES; ETHANOLAMINES; LIGANDS; ZINC;

EID: 0037043532     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol020077n     Document Type: Article

References (34)

1. For recent reviews on nitroaldol reactions, see: (a) Rosini, G. In Comprehensive Organic Synthesis; Trost, B. M., Ed.; Pergamon: Oxford, 1996; Vol. 2, p 321.
2. (b) Luzzio, F. A. Tetrahedron 2001, 57, 915.
3. (c) Ono, N. The Nitro Group in Organic Synthesis; Wiley-VCH: New York, 2001; Chapter 3, p 30.
4. (a) Sasai, H.; Suzuki, T.; Arai, S.; Arai, T.; Shibasaki, M. J. Am. Chem. Soc. 1992, 114, 4418.
5. (b) Sasai, H.; Tokunaga, T.; Watanabe, S.; Suzuki, T.; Itoh, N.; Shibasaki, M. J. Org. Chem. 1995, 60, 7388.
6. (c) For a review, see: Shibasaki, M.; Sasai, H.; Arai, T. Angew. Chem., Int. Ed. Engl. 1997, 36, 1236.
7. (a) Trost, B. M.; Ito, H. J. Am. Chem. Soc. 2000, 122, 12003.
8. (b) Trost, B. M.; Ito, H.; Silcoff, E. R. J. Am. Chem. Soc. 2001, 123, 3367.
9. (c) Trost, B. M.; Silcoff, E. R.; Ito, H. Org. Lett. 2001, 3, 2497.
10. Trost B. M.; Yeh, V. S. C. Angew. Chem., Int. Ed. 2002, 41, 861.
11. (a) Van Der Boom, M. E.; Liou, S.-Y.; Ben-David, Y.; Shimon, L. J. W.; Milstein, D. J. Am. Chem. Soc. 1998, 120, 6531.
12. (b) Arnaud, N.; Picard, C.; Cazaux, L.; Tisnes, P. Tetrahedron 1997, 53, 13757.
13. (c) Finn, L, J. Appl. Chem. 1951, 1, 524.
14. (d) Mendoza, J. Nieto, M. P. Prados, P. Sanchez, C. Tetrahedron 1990, 46, 671-682.
15. (a) Kanth, J. V. B.; Periasamy, M. Tetrahedron 1993, 49, 5127.
16. (b) Xavier, L. C.; Mohan, J. J.; Mathre, D. J.; Thompson, A. S.; Carroll, J. D.; Corley, E. G.; Desmond, R. Org. Synth. 1997, 74, 50 and references therein.
17. (a) Bertz, S. H. Synthesis 1980, 708.
18. (b) Fahrni, C. J.; Pfaltz, A. Helv. Chim. Acta 1998, 81, 491.
19. (a) Turtle R. R.; Brown, C. E. Eur. Pat. Appl. 329,464;
20. Chem Abstr. 1991, 114, 602.
21. (b) Turtle R. R.; Brown, C. E. U.S. Patent 5,395,970, 1989, 1995 (both to Gensia); Chem. Abstr. 1996, 124, 331421
22. (b) Turtle R. R.; Brown, C. E. U.S. Patent 5,395,970, 1989, 1995 (both to Gensia); Chem. Abstr. 1996, 124, 331421
23. (c) Young, M.; Pan, W.; Wiesner, D.; Bullough, G.; Balow, G.; Potter, S.; Metzner, K.; Mullane, K. Drug Dev. Res. 1994, 32, 19.
24. (d) Hammond, H. K.; Mckirnan, M. D. J. Am. Coll. Cardiol. 1994, 23, 475.
25. (e) For previous asymmetric synthesis, see: Takaoka, E.; Yoshikawa, N.; Yamada, Y. M. A.; Sasai, H.; Shibasaki, M. Heterocycles 1997, 46, 157.
26. Biological activities: (a) Yokoyama, H.; Yanagisawa, T.; Taira, N. J. Cardiovasc. Pharmacol. 1988, 12, 323.
27. (b) Bristow, M. R.; Hershberger, R. E.; Port, J. D.; Minobe, W.; Rasmussen, R. Mol. Pharmacol. 1989, 35, 295.
28. Syntheses: (c) Nogushi, K.; Irie, K. Japanese Patent 79 70,233, 1979; Chem. Abstr. 1979, 91, 630.
29. Syntheses: (c) Nogushi, K.; Irie, K. Japanese Patent 79 70,233, 1979; Chem. Abstr. 1979, 91, 630.
30. (d) Nogushi, K.; Irie K. Japanese Patent 79 70,231, 1979; Chem. Abstr. 1979, 91, 630.
31. (d) Nogushi, K.; Irie K. Japanese Patent 79 70,231, 1979; Chem. Abstr. 1979, 91, 630.
32. (e) Ikezaki, M.; Umino, N.; Gaino, M.; Aoe, K.; Iwakuma, T.; Ohishi, T. Yakugaku Zasshi 1986, 106, 80.
33. (f) Corey, E. J.; Link, J. O. J. Org. Chem. 1991, 56, 442.
34. (g) Brown, R. F. C.; Donohue, A. C.; Jackson, W. R.; McCarthy, T. D. Tetrahedron 1994, 50, 13739.